Methods for making a synthetic gene
AssigneeAgBiome, Inc.
InventorJAMES R. HENRIKSEN
Life of this patent
Estimating the term…
Loading patent…
AssigneeAgBiome, Inc.
InventorJAMES R. HENRIKSEN
Estimating the term…
Methods for making a synthetic gene are provided. The methods find use in optimizing a candidate gene nucleic acid sequence for expression in a selected target expression system. The method identifies stable or retained sequences in the candidate gene nucleic acid sequence, identifies disallowed sequences, develops a statistical model based on a whole genome, a partial genome, or transcriptome sequences of the target expression system, generates an optimized candidate gene nucleic acid sequence for use in the target expression system, and makes a synthetic gene comprising the optimized candidate gene nucleic acid sequence. The method allows for optimization of the candidate gene nucleic acid sequence without removing certain stable or retained sequences. Rather, the activity of these sites is positionally modulated or inactivated through upstream and downstream modifications of codons and/or sequence patterns.
1) A method for making a synthetic gene, said method comprising:
4) The method of any preceding claim, wherein the target expression system comprises a target organism or a target in vitro expression system.
5) The method of any preceding claim, wherein the one or more stable or retained sequences comprise polyadenylation sites, termination sites, RNA destabilizing sites, ATTTA motifs, exon-intron splice site signals, transposon-like repeats, restriction enzyme recognition sites, sequences deleterious to gene expression, or any combination thereof.
6) The method of any preceding claim, wherein the one or more disallowed sequences comprise polyadenylation sites, termination sites, RNA destabilizing sites, ATTTA motifs, exon-intron splice site signals, transposon-like repeats, restriction enzyme recognition sites, sequences deleterious to gene expression, or any combination thereof.
7) The method of any preceding claim, wherein the one or more disallowed sequences are scored.
8) The method of any preceding claim, wherein selected subsets of the whole genome, the partial genome, or the transcriptome sequences are used for developing the statistical model.
9) The method of any preceding claim, wherein selected subsets of the whole genome, the partial genome, or the transcriptome sequences are weighted in the statistical model.
10) The method of any preceding claim, wherein the statistical model further comprises compositional patterns in the whole genome, the partial genome, or the transcriptome sequences of the target expression system.
13) The method of any preceding claim, wherein the localized modifications of the candidate gene nucleic acid sequence comprise substitutions of one or more codons that are 5′ to the one or more stable or retained sequences, 3′ to the one or more stable or retained sequences, or a combination thereof.
14) The method of any preceding claim, wherein the localized modifications of the candidate gene nucleic acid sequence comprise substitutions of one or more sequence patterns that are 5′ to the one or more stable or retained sequences, 3′ to the one or more stable or retained sequences, or a combination thereof.
15) The method of any preceding claim, wherein the modifications of additional loci throughout the candidate gene nucleic acid sequence comprise modifications to all regularly spaced or defined loci, wherein the modifications do not include the one or more stable or retained sequences or previously modified sequences.
16) The method of any preceding claim, wherein the modifications of additional loci throughout the candidate gene nucleic acid sequence comprise localized modifications of the one or more disallowed sequences.
17) The method of any preceding claim, wherein the modifications of additional loci throughout the candidate gene nucleic acid sequence comprise one or more substitutions of codons that are present at corresponding positions in the target expression system.
18) The method of any preceding claim, wherein preferences for the modifications of localized sequences in the candidate gene nucleic acid sequence, and preferences for the modifications of additional loci throughout the candidate gene nucleic acid sequence, are based on:
19) The method of any preceding claim, wherein preferences for modifications of the candidate gene nucleic acid sequence are scored simultaneously with weighted scores or are scored in separate sub-steps.
20) The method of any preceding claim, wherein the frequency of codon preference in the target expression system determined by the statistical model is normalized.
21) The method of any preceding claim, wherein the candidate gene nucleic acid sequence and the optimized candidate gene nucleic acid sequence encode the same polypeptide.
Dependencies are inferred from the claim text.